Cargando…
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
Expression of the SS18/SYT-SSX fusion protein is believed to underlie the pathogenesis of synovial sarcoma (SS). Recent evidence suggests that deregulation of the Wnt pathway may play an important role in SS but the mechanisms whereby SS18-SSX might affect Wnt signaling remain to be elucidated. Here...
Autores principales: | Cironi, Luisa, Petricevic, Tanja, Fernandes Vieira, Victor, Provero, Paolo, Fusco, Carlo, Cornaz, Sandrine, Fregni, Giulia, Letovanec, Igor, Aguet, Michel, Stamenkovic, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764983/ https://www.ncbi.nlm.nih.gov/pubmed/26905812 http://dx.doi.org/10.1038/srep22113 |
Ejemplares similares
-
SS18-SSX drives CREB activation in synovial sarcoma
por: Cyra, Magdalene, et al.
Publicado: (2022) -
The clinical implication of SS18-SSX fusion gene in synovial sarcoma
por: Ren, T, et al.
Publicado: (2013) -
Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma
por: Ishii, Midori, et al.
Publicado: (2018) -
Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
por: Raquib, Ainiah Rushdiana, et al.
Publicado: (2022) -
Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)